On January 2nd, the Psomagen-Macrogen Consortium announced the acquisition of all key assets of US company uBiome. Through the move, Psomagen has become a key player in the microbiome sector, a promising next-generation bio healthcare industry, with a competitive advantage in the US and global markets. The acquisition includes a microbiome patent portfolio comprising 246 patents (60 registered US patents and 186 applications), anonymized microbiome data, nearly 300,000 samples, and laboratory equipment from uBiome’s laboratory in San Francisco. The acquisition price is USD 7.05 million, corresponding to 1% of uBiome’s estimated corporate value.
Read the full article: Psomagen-Macrogen Consortium Acquires All Patents and Data from US Company uBiome //
Source: https://www.businesswire.com/news/home/20200102005156/en/Psomagen-Macrogen-Consortium-Acquires-Patents-Data-Company-uBiome